Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Acetylcysteine/bromelain - Mucpharm

Next Previous
Drug Profile

Acetylcysteine/bromelain - Mucpharm

Alternative Names: BromAc; Bromelain/acetylcysteine - Mucopharm

Latest Information Update: 28 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Mucpharm
  • Class Anti-inflammatories; Antibronchitics; Antidotes; Antineoplastics; Cysteine endopeptidases; Expectorants; Mucolytics; Reducing agents; Skin disorder therapies; Small molecules; Sulfur amino acids
  • Mechanism of Action Antioxidants; Free radical inhibitors; Glutamate receptor modulators; Mucin inhibitors; Peptide hydrolase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pseudomyxoma peritonei
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Adenocarcinoma
  • No development reported COVID 2019 infections; Peritoneal cancer; Respiration disorders

Most Recent Events

  • 28 Aug 2025 No recent reports of development identified for phase-I development in COVID-2019-infections(In the elderly, In volunteers, In adults) in Australia (Inhalation, Liquid)
  • 28 Mar 2025 No recent reports of development identified for clinical-Phase-Unknown development in Peritoneal-cancer in Unknown (Intraperitoneal)
  • 28 Mar 2025 No recent reports of development identified for phase-I development in Respiration-disorders in Unknown (Inhalation, Liquid)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top